Evidence map›Paper›PMID 33246470›Full record

ArticleMalaria journal2020

Population genetic analysis of the Plasmodium falciparum circumsporozoite protein in two distinct ecological regions in Ghana.

Elikplim A Amegashie, Lucas Amenga-Etego, Courage Adobor, Peter Ogoti, Kevin Mbogo, Alfred Amambua-Ngwa, Anita Ghansah

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Genomic Insights Into Host Shifts BetweenEvolutionary applications · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Genetic polymorphism ofFrontiers in parasitology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Genetic polymorphism and evidence of signatures of selection in themedRxiv : the preprint server for health sciences · 2024
    Article
  15. Genetic variation of theFrontiers in parasitology · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Elikplim A AmegashieDepartment of Biochemistry, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya.
Lucas Amenga-EtegoDepartment of Biochemistry, Cell and Molecular Biology, West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Legon, Ghana.
Courage AdoborParasitology Department, Noguchi Memorial Institute of Medical Research, University of Ghana, , Legon, Ghana.
Peter OgotiDepartment of Biochemistry, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya.
Kevin MbogoDepartment of Biochemistry, Jomo Kenyatta University of Agriculture and Technology, Juja, Kenya.
Alfred Amambua-NgwaDisease Control and Elimination, Medical Research Council Unit, The Gambia Unit, Bakau, The Gambia.
Anita GhansahParasitology Department, Noguchi Memorial Institute of Medical Research, University of Ghana, , Legon, Ghana. aghansah@noguchi.ug.edu.gh.ORCID http://orcid.org/0000-0003-4639-1249
Jomo Kenyatta University of Agriculture and Technology · KEUniversity of Ghana · GHMRC Unit the Gambia · GM

Funding

Wellcome TrustWellcome Trust 107740/Z/15/Z
6 · The paper itself

Abstract

backgroundExtensive genetic diversity in the Plasmodium falciparum circumsporozoite protein (PfCSP) is a major contributing factor to the moderate efficacy of the RTS,S/AS01 vaccine. The transmission intensity and rates of recombination within and between populations influence the extent of its genetic diversity. Understanding the extent and dynamics of PfCSP genetic diversity in different transmission settings will help to interpret the results of current RTS,S efficacy and Phase IV implementation trials conducted within and between populations in malaria-endemic areas such as Ghana.

methodsPfcsp sequences were retrieved from the Illumina-generated paired-end short-read sequences of 101 and 131 malaria samples from children aged 6-59 months presenting with clinical malaria at health facilities in Cape Coast (in the coastal belt) and Navrongo (Guinea savannah region), respectively, in Ghana. The sequences were mapped onto the 3D7 reference strain genome to yield high-quality genome-wide coding sequence data. Following data filtering and quality checks to remove missing data, 220 sequences were retained and analysed for the allele frequency spectrum, genetic diversity both within the host and between populations and signatures of selection. Population genetics tools were used to determine the extent and dynamics of Pfcsp diversity in P. falciparum from the two geographically distinct locations in Ghana.

resultsPfcsp showed extensive diversity at the two sites, with the higher transmission site, Navrongo, exhibiting higher within-host and population-level diversity. The vaccine strain C-terminal epitope of Pfcsp was found in only 5.9% and 45.7% of the Navrongo and Cape Coast sequences, respectively. Between 1 and 6 amino acid variations were observed in the TH2R and TH3R epitope regions of PfCSP. Tajima's D was negatively skewed, especially for the population from Cape Coast, given the expected historical population expansion. In contrast, a positive Tajima's D was observed for the Navrongo P. falciparum population, consistent with balancing selection acting on the immuno-dominant TH2R and TH3R vaccine epitopes.

conclusionThe low frequencies of the Pfcsp vaccine haplotype in the analysed populations indicate a need for additional molecular and immuno-epidemiological studies with broader temporal and geographic sampling in endemic populations targeted for RTS,S application. These results have implications for the efficacy of the vaccine in Ghana and will inform the choice of alleles to be included in future multivalent or chimeric vaccines.

Indexed as

Genetic VariationChild, PreschoolEnvironmentGhanaHumansInfantPlasmodium falciparumProtozoan Proteinscircumsporozoite protein, ProtozoanProtozoan ProteinsGenetic diversityPlasmodium falciparum circumsporozoite proteinSelectionWithin-host diversity

Identifiers

PMID33246470
PMCPMC7694917
OpenAlexW3109461198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.